Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies.

Stamerra CA, Di Giosia P, Giorgini P, Ferri C, Sukhorukov VN, Sahebkar A

Open source

DOI
10.1155/2022/9530007
Published
2022
Container
Oxidative medicine and cellular longevity
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/9530007,
  title = {Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies.},
  author = {Stamerra CA and Di Giosia P and Giorgini P and Ferri C and Sukhorukov VN and Sahebkar A},
  year = {2022},
  journal = {Oxidative medicine and cellular longevity},
  doi = {10.1155/2022/9530007},
  url = {https://doi.org/10.1155/2022/9530007}
}

RIS

TY  - JOUR
TI  - Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies.
AU  - Stamerra CA
AU  - Di Giosia P
AU  - Giorgini P
AU  - Ferri C
AU  - Sukhorukov VN
AU  - Sahebkar A
PY  - 2022
JO  - Oxidative medicine and cellular longevity
DO  - 10.1155/2022/9530007
UR  - https://doi.org/10.1155/2022/9530007
ER  - 

APA

CA, S., P, D. G., P, G., C, F., VN, S., & A, S. (2022). Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies.. Oxidative medicine and cellular longevity. https://doi.org/10.1155/2022/9530007

Source records